{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:20:31Z","timestamp":1787016031855,"version":"build-2736575974"},"reference-count":47,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Urinary tract infections (\n                      <jats:styled-content style=\"fixed-case\">UTI<\/jats:styled-content>\n                      s) are the most common infectious complications among renal transplant recipients (\n                      <jats:styled-content style=\"fixed-case\">RTR<\/jats:styled-content>\n                      ).\n                      <jats:styled-content style=\"fixed-case\">UTI<\/jats:styled-content>\n                      s caused by extended\u2010spectrum beta\u2010lactamase (\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      )\u2010producing Enterobacteriaceae (\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>\n                      ) have been associated with inferior clinical outcomes and increased financial burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a systematic review and meta\u2010analysis by searching through the PubMed and\n                      <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content>\n                      databases (to May 20, 2016) and identifying studies that reported data on the number of\n                      <jats:styled-content style=\"fixed-case\">RTR<\/jats:styled-content>\n                      who developed an\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE UTI<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our analysis included seven studies, out of 357 non\u2010duplicate articles, that provided data on 2824 patients. Among them, 10% (95% confidence interval [\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ] 4%\u201017%) developed an\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE UTI<\/jats:styled-content>\n                      over their follow\u2010up periods. The proportion of\n                      <jats:styled-content style=\"fixed-case\">RTR<\/jats:styled-content>\n                      affected by an\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE UTI<\/jats:styled-content>\n                      was 2% in North America (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1%\u20103%), 5% in Europe (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      4%\u20106%), 17% in South America (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      10%\u201027%), and 33% in Asia (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      27%\u201041%). In addition, patients affected with an\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE UTI<\/jats:styled-content>\n                      were 2.75\u2010times (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      1.97\u20103.83) more likely to suffer a recurrent\n                      <jats:styled-content style=\"fixed-case\">UTI<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Based on a limited number of studies, one in 10\n                      <jats:styled-content style=\"fixed-case\">RTR<\/jats:styled-content>\n                      will develop a\n                      <jats:styled-content style=\"fixed-case\">UTI<\/jats:styled-content>\n                      caused by an\n                      <jats:styled-content style=\"fixed-case\">ESBL<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>\n                      , and these patients face an almost 3 times greater risk of recurrence. A more rigorous monitoring of\n                      <jats:styled-content style=\"fixed-case\">RTR<\/jats:styled-content>\n                      , both during and after resolution of their infection, should be evaluated in order to reduce the incidence and the clinical impact of these resistant infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.12759","type":"journal-article","created":{"date-parts":[[2017,8,13]],"date-time":"2017-08-13T01:26:35Z","timestamp":1502587595000},"source":"Crossref","is-referenced-by-count":54,"title":["Urinary tract infections caused by\n                    <scp>ESBL<\/scp>\n                    \u2010producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"19","author":[{"given":"Michail","family":"Alevizakos","sequence":"first","affiliation":[{"name":"Infectious Diseases Division Warren Alpert Medical School of Brown University Rhode Island Hospital Rhode Island RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Nasioudis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Weill Cornell Medical College New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-0777","authenticated-orcid":false,"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division Warren Alpert Medical School of Brown University Rhode Island Hospital Rhode Island RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.883901"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00519.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182a04997"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01700.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.236.175"},{"key":"e_1_2_9_7_1","first-page":"1311","article-title":"Urinary tract infections following renal transplantation: A single\u2010center experience","volume":"23","author":"Barbouch S","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2014.05.006"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2007.02.060"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.05.014"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/319757"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2013.875515","article-title":"Colonization and infection with extended spectrum beta\u2010lactamase producing Enterobacteriaceae in high\u2010risk patients \u2013 Review of the literature from a clinical perspective","volume":"42","author":"Biehl LM","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks301"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin\u2010tazobactam for patients with extended\u2010spectrum beta\u2010lactamase bacteremia","volume":"60","author":"Tamma PD","year":"2015","journal-title":"Clin Infect Dis"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.2157"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12366"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.02014.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12124"},{"key":"e_1_2_9_20_1","unstructured":"WellsGA SheaB O'ConnellD et\u00a0al.The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta\u2010analyses.2000.http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed September 1 2016."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/2049-3258-72-39"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-79"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1187"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw283"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091289"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P661"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.02.002"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.4103\/1596-3519.93527"},{"issue":"3","key":"e_1_2_9_31_1","first-page":"11","article-title":"Early infections in renal transplant recipients: Incidence, risk factors, and causative microorganisms","volume":"13","author":"Yabanoglu H","year":"2015","journal-title":"Exper Clin Transplant"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13075"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/23744235.2015.1051107"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2012.00744.x"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.12.011"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.08.018"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02197.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2008.01019.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12465"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1086\/320905"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12196"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn241"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12733"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.08.021"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00473-0"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2016.02.001"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.01.009"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.137653"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:29:16Z","timestamp":1750789756000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1111\/tid.12759"],"URL":"https:\/\/doi.org\/10.1111\/tid.12759","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"article-number":"e12759"}}